Could a Face-Mounted device replace sleep labs?
NCT ID NCT04583826
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tested a medical device called CAVA that uses electrodes on the face to record eye movements during sleep. Nine volunteers wore the device along with standard sleep monitoring equipment in a sleep lab. The goal was to see if CAVA could accurately classify sleep stages (REM, non-REM, awake) using computer algorithms, potentially offering a simpler way to monitor sleep at home.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- CAVA device (face-mounted ECG electrodes for recording eye movements)
- What this could lead to
- If successful, this could lead to a simple home device for tracking sleep stages without needing a sleep lab.
- What could go wrong
- This was a very small early study with only 9 participants, so results may not apply to everyone. The device is still experimental and not yet proven for home use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLEEP are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Norfolk and Norwich University Hospitals NHS Foundation Trust
Norwich, Norfolk, NR47UY, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A 45-Minute lesson could sharpen Students' minds and sleep
- Can a sleepless night rewire hunger and memory?
- Melatonin bath products: are they absorbed like pills?
- Can a strange bed sabotage your workout? sex differences put to the test
- Can your pupils reveal the secrets of sleep and body clocks?
- Can fish oil calm ADHD and autism symptoms? a new trial investigates